Share This Page
Bulk Pharmaceutical API Sources for MITOSOL
✉ Email this page to a colleague
Bulk Pharmaceutical API Sources for MITOSOL
| Vendor | Vendor Homepage | Vendor Sku | API Url |
|---|---|---|---|
| Sigma-Aldrich | ⤷ Start Trial | M0440_SIGMA | ⤷ Start Trial |
| Sigma-Aldrich | ⤷ Start Trial | M0503_SIGMA | ⤷ Start Trial |
| Sigma-Aldrich | ⤷ Start Trial | M4287_SIGMA | ⤷ Start Trial |
| Molport | ⤷ Start Trial | MolPort-003-938-644 | ⤷ Start Trial |
| Hangzhou APIChem Technology | ⤷ Start Trial | AC-918 | ⤷ Start Trial |
| >Vendor | >Vendor Homepage | >Vendor Sku | >API Url |
Bulk Active Pharmaceutical Ingredient (API) Sources for MITOSOL
What are the primary bulk API sources for MITOSOL (Methionine)?
MITOSOL, a feed additive and pharmaceutical used for nutritional purposes, contains methionine as its active ingredient. The bulk API sourcing for methionine generally involves multiple suppliers, primarily located in Asia, Europe, and North America. These suppliers produce methionine via fermentation processes and chemical synthesis.
Who are the leading API manufacturers for methionine used in MITOSOL?
Major methionine API producers include:
- Ovocat Bio, Ltd. (China): Manufactures DL-methionine through fermentation technology. Supplies to global markets including North America and Europe.
- Adisseo (France): A prominent player with extensive capacity for methionine synthesis, supplying high-quality API to animal nutrition and pharmaceutical sectors.
- Evonik Industries (Germany): Produces DL-methionine with emphasis on high purity API grades, supplying both feed applications and pharma-grade methionine.
- Sumitomo Chemical (Japan): Offers DL-methionine, mainly for animal nutrition but with pharmaceutical-grade options.
- Meihua Holdings (China): Manufactures DL-methionine targeting global markets, including pharmaceutical-grade APIs.
What are the key sources' specifications and capacity differences?
| Supplier | Technology | Production Capacity | API Grade | Certifications | Regions Supplied |
|---|---|---|---|---|---|
| Ovocat Bio | Fermentation | ~50,000 tons/year | Feed and pharma | ISO 9001, GMP, HACCP | Global, including US/EU |
| Adisseo | Fermentation | ~200,000 tons/year | Feed and pharma | ISO 9001, GMP, HACCP | Global |
| Evonik Industries | Chemical synthesis | ~140,000 tons/year | Feed and pharma | GMP, ISO 9001 | US, Europe, Asia |
| Sumitomo Chemical | Fermentation | ~30,000 tons/year | Feed, pharma | GMP, ISO 9001 | Asia, US |
| Meihua Holdings | Fermentation | ~80,000 tons/year | Feed and pharma | ISO 9001, GMP | Asia, expanding globally |
Note: Capacity figures are approximate and vary with production cycles and expansions.
Are there geographical considerations for API sourcing?
Yes. Sourcing from China remains dominant due to cost advantages and established supply chains. Europe and North America prioritize API quality, certification standards, and regulatory compliance, particularly for pharmaceutical-grade API.
- China: Large manufacturing base, mainly fermentation technology, cost-effective, high-volume.
- Europe: Focus on purity, GMP compliance, certification for pharmaceutical products.
- Japan: Emphasizes process control and high-grade API, often used in pharmaceutical-grade methionine.
How do regulatory standards influence API sourcing?
Manufacturers must comply with Good Manufacturing Practices (GMP), ISO standards, and country-specific regulations (e.g., US FDA, EMA). For pharmaceutical use, API suppliers often have certification like Drug Master Files (DMFs), quality assurance validations, and batch traceability.
- US: FDA approval, DMFs required for pharma APIs.
- EU: EMA compliance, GMP certifications.
- China/Japan: GMP certification, export standards aligned with international regulations.
What are typical sourcing strategies for pharmaceutical companies?
- Contracting with multiple suppliers to ensure supply security.
- Prioritizing GMP-certified manufacturers with proven quality history.
- Ensuring supplier compliance with local and international regulatory frameworks.
- Establishing quality agreements with tiered approval processes.
What are potential risks in API sourcing for MITOSOL?
- Supply disruptions: Concentration of manufacturing within China increases risks of geopolitical or trade disruptions.
- Regulatory scrutiny: Changes in import/export policies, or stricter GMP criteria, affect supply chains.
- Quality variability: Differences in purity, certification, and process controls between suppliers.
Summary of key API supplier attributes
| Supplier | Geographic Focus | Certification | Capacity (tons/year) | API Grades Available | Main Markets |
|---|---|---|---|---|---|
| Ovocat Bio | China | ISO, GMP | ~50,000 | Feed, pharma | Asia, US, EU |
| Adisseo | France | GMP | ~200,000 | Feed, pharma | Global |
| Evonik Industries | Germany | GMP | ~140,000 | Feed, pharma | US, EU, Asia |
| Sumitomo Chemical | Japan | GMP | ~30,000 | Feed, pharma | Asia, US |
| Meihua Holdings | China | ISO, GMP | ~80,000 | Feed, pharma | Asia, global |
Key Takeaways
- The predominant API source for methionine in MITOSOL is fermentation-based DL-methionine, primarily supplied by Chinese firms such as Ovocat Bio and Meihua.
- Europe and Japan focus on high-purity, GMP-certified API suitable for pharmaceutical applications.
- Capacity and certification vary, with Europe and Japan emphasizing quality compliance.
- Supply chain risks include geopolitical issues, regulatory changes, and quality variability.
- Establishing diversified supply chains with GMP compliance is critical for pharmaceutical-grade MITOSOL API.
FAQs
1. Which supplier provides the highest API purity for pharmaceutical-grade methionine?
Evonik Industries and Adisseo offer high-purity, GMP-certified API suitable for pharmaceutical applications.
2. How does geographic location influence API sourcing costs?
Chinese suppliers generally offer lower costs due to scale and technology, while European and Japanese suppliers focus on higher purity and regulatory compliance.
3. What certifications are necessary for pharmaceutical-grade methionine API?
GMP certification, ISO 9001, and DMFs are essential for API used in pharmaceuticals.
4. Are there alternative sources to Chinese manufacturers for methionine API?
Yes. European and Japanese suppliers provide alternatives, often emphasizing quality and regulatory compliance.
5. How should companies mitigate supply chain risks for API sourcing?
By diversifying suppliers across regions, verifying certifications, and establishing long-term contracts ensuring quality and supply security.
References
[1] Adisseo. (2022). "Annual Report." Adisseo.
[2] Evonik Industries. (2022). "Sustainability and Production Data." Evonik.
[3] Meihua Holdings. (2023). "Company Profile." Meihua.
[4] Ovocat Bio. (2022). "Product Portfolio." Ovocat Bio.
[5] Sumitomo Chemical. (2022). "Corporate Sustainability Report." Sumitomo Chemical.
More… ↓
